providers and patients alike are relying on clinical trial data to ensure that we are getting the right treatment at the right doses at the right time.

Climate change is a critical issue, and it demands action, and EPA's clean power rules, I believe, are a major step forward.

I have grave concern that if this rule is proposed, it could put that in jeopardy.

it is important for us to be cautious as we evaluate ways to make this program more sustainable and efficient.

As members of the House National Marine Sanctuary Caucus, we write to express our concern regarding the language in the Magnuson-Stevens Act (MSA) reauthorization discussion draft that would preempt key marine Sanctuary management…

We can't and must not ignore the important health care extenders.

Thank you very much. Thank you, Waxman.

I think the evolution of medical apps-and the important balance that must be struck between patient safety and encouraging innovation.

I also encourage the Chairman to look at complementary legislation-the Medical Checklist Act-that Mr. Holt and I have introduced again this Congress.

prepared statement

I am very pleased that FDASIA included parts of my Sentinel Assurance for Effective Devices Act, also known as the SAFE Act, in its final form.